2000
DOI: 10.1016/s0015-0282(00)00559-8
|View full text |Cite
|
Sign up to set email alerts
|

In situ use of pentoxifylline to assess sperm vitality in intracytoplasmic sperm injection for treatment of patients with total lack of sperm movement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(7 citation statements)
references
References 4 publications
0
7
0
Order By: Relevance
“…(Angelopoulos et al, 1999) 5 mmol/L PTX for 10-min incubation In cases with total lack of sperm motility, in situ use of PTX improved sperm assessment. (de Mendoza et al, 2000) 1 mg/ml (3.6 mmol/L) and 30-min incubation (37°C)…”
Section: Ptx Dosage and Incubation Time Conclusion Authorsmentioning
confidence: 99%
“…(Angelopoulos et al, 1999) 5 mmol/L PTX for 10-min incubation In cases with total lack of sperm motility, in situ use of PTX improved sperm assessment. (de Mendoza et al, 2000) 1 mg/ml (3.6 mmol/L) and 30-min incubation (37°C)…”
Section: Ptx Dosage and Incubation Time Conclusion Authorsmentioning
confidence: 99%
“…Viable non-motile sperm can also be identified by incubation in pentoxifylline. Viable sperm will develop motility after exposure to pentoxifylline (26).…”
Section: Sperm Viability Testsmentioning
confidence: 99%
“…The most elegant strategy is the only one that allows for partial restoration of original motility (32), namely, the in situ use of methylxanthines, such as pentoxy-or theophylline.…”
Section: Discussionmentioning
confidence: 99%
“…Rather, they were used with some success to raise motility and, thus, increase outcome in patients with IUI (45) and previous fertilization failure after IVF (46)(47)(48)(49). Since ICSI has become a powerful alternative in such patients, total lack of sperm movement (32) or presence of immotile sperm in microsurgical epididymal sperm aspiration and TESE patients (15,16) are the only indications being left for routine use of methylxanthines such as pentoxy-or theophylline. The latter has not been investigated in detail.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation